Company / EPS (Diluted)
OMEROS CORP EPS (Diluted) History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.76
FY2022
5-year range
-$2.61 / $3.12
FY2018-FY2022
Trend
-75.6%
vs FY2021
Sector context
#36 of 204
Health Care
What the data says
OMEROS CORP's eps (diluted) of $0.76 is higher than 82% of companies in the Health Care sector (FY2022). EPS (Diluted) has fluctuated over the past 8 years, ranging from $-2.61 in FY2020 to $3.12 in FY2021.
Based on SEC 10-K filings.
0.76 in FY2022. Top quartile in the Health Care sector.
Improved from $-2.61 to $0.76 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 204This company $0.76 Sector average -$0.98
▼
+177.6% above sector average
Key checks
Key Insights
- In FY2022, eps (diluted) decreased 75.6% year-over-year.
- Ranks #36 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2021.
- Lowest eps (diluted) in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0.76 | -75.6% |
| FY2021 | $3.12 | +219.5% |
| FY2020 | -$2.61 | -123.1% |
| FY2019 | -$1.17 | +29.1% |
| FY2018 | -$1.65 | +17.5% |
| FY2017 | -$2.00 | +9.9% |
| FY2016 | -$2.22 | -59.7% |
| FY2015 | -$1.39 | +12.6% |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026